Creo Medical wins National Award for Innovation

At an awards event in London last week, the BVCA (British Private Equity & Venture Capital Association) recognised Creo Medical for the innovation of its electrosurgical platform, with wide reaching potential applications BVCA High Growth Conference and MTA 2015

Following the announcement on the regional award a few weeks ago, Creo Medical has won the National Best for Innovation award in the BVCA Management Team Awards for 2015.

Further recognition of the technology designed in collaboration with the world class Gastroenterology team at St Mark’s Hospital, London, the CROMA platform along with the Speedboat RS2 device has been described as “the first new electrosurgical system in a generation”. Providing a unique combination of bipolar radiofrequency energy for precise cutting and microwave energy for controlled coagulation the technology is designed to deliver quicker, safer and more effective results.

Over 150 UK companies were nominated for the 2015 BVCA Management Team Awards in seven categories. Nominations were subject to rigorous due diligence and in-depth interviews by a judging panel of leading industry figures.

Congratulating Creo Medical on winning this award Dr Richard Thompson from Finance Wales’ technology venture investments team said: “Creo Medical is an emerging med-tech leader and its CROMA electrosurgical platform is ground breaking and has significant potential to improve the outcomes of a range of medical procedures.  Creo had already been recognised as a Welsh regional winner, so winning the national Best for Innovation award is even more impressive and clearly demonstrates how truly innovative CROMA is.  Finance Wales is a long-term backer of Creo Medical and it has made excellent progress since we helped to relocate its headquarters to Wales.  The company has a bright future and we congratulate Craig and his team on their success.”

Chris Hancock, Inventor & co-founder of Creo Medical said: “This award will help further engage the creative spirit of the company & lead to the development of exciting innovation in medical devices solving unmet clinical needs”

The BVCA is the industry body for private equity and venture capital in the UK, embracing over 230 private equity and venture capital houses reinforcing the crucial role the industry plays in the global economy as a catalyst for change and growth.

BVCA_Award_Team jpeg